Bionomics | Investor Presentation Deck | 16 slides

Bionomics · 2022-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

16
every slide · same image gating as the playbook
01
Slide 1
Features a stylized brain-circuitry graphic.front_matter
03
The slide uses a list-based layout to summarize key company milestones and strategic pillars.summarize
04
The slide uses a standard pharmaceutical pipeline visualization format.plan_implementation
05
frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
06
The slide combines a bar chart for revenue projections and a segmented pie/fan chart for patient population sizing.size_opportunity
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
07
The slide uses a checkmark/cross matrix to highlight the competitive advantage of BNC210.compare_peers
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
08
The slide uses a list-based framework to justify the clinical development path.argue_timing
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
09
The slide uses a split-layout: left side lists clinical symptoms/causes, right side details functional impact on life domains.frame_problem
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
10
The slide uses a combination of a bar chart for revenue projections and a layered pie/segmentation graphic for patient population sizing.size_opportunity
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
11
The slide uses a central head-shaped graphic to frame the core thesis, with supporting evidence listed to the right.argue_timing
Open slide detailBeat · Solution (Provide relief)Loop · Why Now
12
The slide highlights both financial traction (milestones) and clinical progress (Phase 1 trials).show_traction
13
The slide presents clinical trial data showing the efficacy of MDMA-assisted therapy compared to placebo, followed by the strategic rationale for a partnership.show_traction
14
Figures as of March 30, 2022.summarize
15
The slide uses a vertical timeline structure to present key corporate and clinical milestones.plan_implementation
16
summarize